Gross profit · 2021–2025
Beone Medicines gross profit
$4.7B+45.3% · FY2025
Beone Medicines (ONC) reported $4.7B in gross profit for fiscal 2025, +45.3% year on year.
Gross profit — Gross profit is revenue minus the direct cost of goods and services sold. Not every company reports it; those that do not are absent from this ranking.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2021–2025 compound annual growth +46.6%
Gross profit at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Beone Medicines gross profit |url=https://companiesranked.com/en/company/beone-medicines/gross-profit |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Beone Medicines gross profit. CompaniesRanked. https://companiesranked.com/en/company/beone-medicines/gross-profitBibTeX
@misc{companiesranked-en-company-beone-medicines-gross-profit-2026,
author = {{CompaniesRanked}},
title = {{Beone Medicines gross profit}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/beone-medicines/gross-profit}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-011946 · February 26, 2026
{{cite web |title=Beone Medicines gross profit — 10-K (0001628280-26-011946) |url=https://www.sec.gov/Archives/edgar/data/1651308/000162828026011946/bgne-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.